ghk cu somatostatin The somatostatin-secreting pancreatic δ-cell in health and disease Copper tripeptide (GHK-Cu) | Tripeptide

not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile

Don't increase too quickly

"P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling"

Acupuncture, stress reduction, anti-inflammatory nutrition, and targeted supplements like magnesium may help reduce pain frequency and severity

after NSAIDs or insulin overdose or cuprizone encephalopathies were attenuated along with GI, liver and vascular injuries